Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation

NCT07206693 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07206693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07206693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
January 1, 2007
Completion date
December 31, 2023
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate cancer screening, prostate cancer screening decision, prostate specific antigen screening